Sakashita Naomi, Ando Yukio, Haraoka Katsuki, Terazaki Hisayasu, Yamashita Taro, Nakamura Masaaki, Takeya Motohiro
Department of Cell Pathology, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
Pathol Int. 2006 Jul;56(7):408-12. doi: 10.1111/j.1440-1827.2006.01978.x.
Reported herein is an autopsy case of familial amyloidotic polyneuropathy (FAP) with cardiac liver cirrhosis associated with amyloid cardiomyopathy after liver transplantation. At 47 years of age a Japanese woman with a transthyretin Val30Met mutation and sensorimotor polyneuropathy underwent liver transplantation; no postoperative deterioration related to the graft or polyneuropathy occurred. However, cardiovascular dysfunction associated with amyloid deposition gradually worsened. Pacemaker implantation and diuretics were ineffective against the heart failure; 10 years after transplantation the patient died. Autopsy revealed massive pleural and pericardial effusions and amyloid cardiomyopathy, especially in the right atrium and cardiac conduction system. Amyloid deposition was slight in all organs except the heart, but liver cirrhosis with reversed lobulation and centrilobular hemorrhagic necrosis was prominent. There was no histological evidence for chronic liver graft rejection. These findings suggest that liver transplantation effectively stopped amyloid deposition and ameliorated clinical FAP symptoms but that amyloid cardiomyopathy after liver transplantation in advanced clinical stages may lead to severe congestive heart failure and cardiac liver cirrhosis.
本文报告了一例家族性淀粉样多神经病(FAP)尸检病例,该患者在肝移植后出现与淀粉样心肌病相关的心脏性肝硬化。一名47岁患有转甲状腺素蛋白Val30Met突变和感觉运动性多神经病的日本女性接受了肝移植;术后未出现与移植物或多神经病相关的病情恶化。然而,与淀粉样蛋白沉积相关的心血管功能障碍逐渐加重。起搏器植入和利尿剂对心力衰竭无效;移植10年后患者死亡。尸检发现大量胸腔和心包积液以及淀粉样心肌病,尤其是在右心房和心脏传导系统。除心脏外,所有器官的淀粉样蛋白沉积均轻微,但具有反向小叶形成和小叶中心出血性坏死的肝硬化较为突出。没有慢性肝移植排斥反应的组织学证据。这些发现表明,肝移植有效地阻止了淀粉样蛋白沉积并改善了临床FAP症状,但晚期临床阶段肝移植后的淀粉样心肌病可能导致严重的充血性心力衰竭和心脏性肝硬化。